Canada markets closed

CanSino Biologics Inc. (CASBF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
2.10000.0000 (0.00%)
At close: 11:28AM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
358,911
345,182
1,031,041
4,299,702
18,544
Cost of Revenue
1,202,247
1,221,201
1,217,648
1,297,769
13,804
Gross Profit
-843,336
-876,019
-186,607
3,001,933
4,740
Operating Expenses
Research Development
584,968
637,987
778,257
878,718
428,485
Selling General and Administrative
639,450
647,847
544,680
337,631
99,437
Total Operating Expenses
1,142,809
1,202,887
1,261,962
1,201,354
445,063
Operating Income or Loss
-1,986,145
-2,078,906
-1,448,569
1,800,579
-440,323
Interest Expense
70,056
64,145
41,341
20,419
0
Income Before Tax
-1,953,301
-1,978,884
-1,184,001
1,936,787
-396,638
Income Tax Expense
18,816
-11,451
-219,244
29,701
0
Income from Continuing Operations
-1,972,117
-1,967,433
-964,757
1,907,086
-396,638
Net Income
-1,513,280
-1,482,732
-909,431
1,914,390
-396,638
Net Income available to common shareholders
-1,513,280
-1,482,732
-909,431
1,914,390
-396,638
Basic EPS
-1.08
-6.01
-3.68
7.74
-1.72
Diluted EPS
-1.08
-6.01
-3.68
7.74
-1.72
Basic Average Shares
223,015
246,766
247,022
247,450
230,917
Diluted Average Shares
223,015
246,766
247,022
247,450
230,917